アメリカの神経血管装置市場2020年-2027年:製品別(塞栓装置、血行再建装置、血栓摘出装置、塞栓保護装置、付属装置)、疾患別

◆英語タイトル:U.S. Neurovascular Devices Market by Product (Embolization Devices, Revascularization Devices, Thrombectomy Devices, Embolic Protection Devices, and Accessory Devices), and Disease Pathology (Aneurysm, Arteriovenous Malformation, Ischemic stroke, Stenosis, and Others): Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード:ALD21FB034
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年12月
◆ページ数:156
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:アメリカ
◆販売価格オプション(消費税別)
Single UserUSD3,249 ⇒換算¥370,386見積依頼/購入/質問フォーム
5 UserUSD3,423 ⇒換算¥390,222見積依頼/購入/質問フォーム
Enterprise UserUSD4,774 ⇒換算¥544,236見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Allied Market Research社の本調査レポートでは、アメリカの神経血管装置市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品別(塞栓装置、血行再建装置、血栓摘出装置、塞栓保護装置、付属装置)分析、疾患別(動脈瘤、動静脈奇形、虚血性脳卒中、狭窄症、その他)分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・アメリカの神経血管装置市場規模:製品別(塞栓装置、血行再建装置、血栓摘出装置、塞栓保護装置、付属装置)
・アメリカの神経血管装置市場規模:疾患別(動脈瘤、動静脈奇形、虚血性脳卒中、狭窄症、その他)
・企業情報
【レポートの概要】

The U.S. neurovascular devices market was valued at $946 million in 2019, and is projected to reach $1,071 million by 2027, registering a CAGR of 3.8% from 2020 to 2027.

Neurovascular devices are defined as instruments and machines, which are employed in the treatment of various neurovascular disorders. In addition, these disorders include medical conditions that affect blood vessels, which supply the brain & spinal cord with oxygenated blood. Thus, neurovascular devices such as revascularization devices, thrombectomy devices, embolic protection devices, and embolization devices are used in the treatment of neurovascular disorders. Moreover, these devices are used in disorders such as aneurysm. For instance, embolization devices are used in occlusion of blood vessels to decrease blood flow, which, in turn, helps in the reduction of blood flow. The other neurovascular devices such as thrombectomy devices are used in conditions such as ischemic stroke. For instance, the thrombectomy devices help in recovering the brain from ischemic disorder if it has not reached the stage of complete infarction. Thus, these neurovascular devices restore perfusion through blocked artery.

The major factor that contributes toward growth of the U.S. neurovascular devices market include rise in geriatric population. In addition, increase in prevalence of neurovascular diseases and rise in adoption of neurovascular devices also contribute toward the growth of the U.S. neurovascular devices market. In addition, other factors such as increase in technological advancements related to neurovascular devices also drive the growth of the U.S. neurovascular devices market.

However, high cost of neurovascular devices restricts the growth of the U.S. neurovascular devices market. Conversely, surge in demand for minimally invasive procedures in the U.S provides lucrative opportunities for players operating in the neurovascular devices market.

The U.S. neurovascular devices market is segmented on the basis of product and disease pathology to provide a detailed assessment of the market. By product, the market is divided into embolization devices, revascularization devices, thrombectomy devices, embolic protection devices, and accessory devices. The embolization devices are further sub-segmented into clippings, embolic coils, coil assist stents, and coil assist balloon. In addition, the embolic coils segment is further divided into bare detachable coils and coated detachable coils. The revascularization device segment is further divided into carotid artery stents and flow diversion stents. The thrombectomy devices segment is divided into clot retrieval devices, suction & aspiration devices, and snares. The embolic protection devices segment is divided in distal filter devices and balloon occlusion devices. Similarly, the accessory devices segment is divided into microcatheters, and micro guidewires. By disease pathology, the market is classified into aneurysm, arteriovenous malformation, ischemic stroke, stenosis, and others.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2019 to 2027, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of factors that drive and restrain the growth of the market is provided.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS
By Product
• Embolization Devices
o Clippings
o Embolic Coils
 Bare Detachable Coils
 Coated Detachable Coils
o Coil Assist Stent
o Coil Assist Balloon
• Revascularization Devices
o Carotid Artery Stents
o Flow Diversion Stents
• Thrombectomy Devices
o Clot Retrieval Devices
o Suction & Aspiration Devices
o Snares
• Embolic Protection Devices
o Distal Filter Devices
o Balloon Occlusion Devices
• Accessory Devices
o Microcatheters
o Micro-guidewires

By Disease Pathology
• Aneurysm
• Arteriovenous Malformation
• Ischemic Stroke
• Stenosis
• Others

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• B. Braun Melsungen AG
• Integer Holdings Corporation
• Johnson & Johnson (Cerenovus)
• Medtronic Plc.
• Merit Medical Systems, Inc.
• Microport Scientific Corporation
• Penumbra, Inc.
• SAES Getters SpA (Memry Corporation)
• Stryker Corporation
• Terumo Corporation (Microvention, Inc.)

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
• W.L. Gore & Associates, Inc.
• Abbott Laboratories
• Acandis GmbH

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top Wining Strategies
3.2.2.Top investment pockets

3.3.Key forces shaping neurovascular devices industry/market
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Growth in prevalence of neurovascular diseases
3.4.1.2.Upsurge in geriatric population across the U.S.
3.4.1.3.Technological developments associated with neurovascular devices
3.4.1.4.Rise in incidence of underlying disease conditions serve as risk neurovascular diseases

3.4.2.Restraint

3.4.2.1.High cost of neurovascular devices

3.4.3.Opportunity

3.4.3.1.Surge in demand for minimally invasive procedures in U.S.

3.4.4.Impact Analyses

3.5.COVID-19 Impact analysis on the market

CHAPTER 4:U.S. NEUROVASCULAR DEVICES MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Embolization devices

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market size and forecast, by type

4.2.3.1.Clippings

4.2.3.1.1.Market size and forecast

4.2.3.2.Embolic Coils

4.2.3.2.1.Market size and forecast
4.2.3.2.2.Bare Detachable Coils

4.2.3.2.2.1.Market size and forecast

4.2.3.2.3.Coated Detachable Coil

4.2.3.2.3.1.Market size and forecast

4.2.3.3.Coil assist stent

4.2.3.3.1.Market size and forecast

4.2.3.4.Coil assist balloon

4.2.3.4.1.Market size and forecast

4.3.Revascularization devices

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market size and forecast, by type

4.3.3.1.Carotid artery stents

4.3.3.1.1.Market size and forecast

4.3.3.2.Flow diversion stents

4.3.3.2.1.Market size and forecast

4.4.Thrombectomy devices

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market size and forecast, by type

4.4.3.1.Clot Retrieval Devices

4.4.3.1.1.Market size and forecast

4.4.3.2.Suction and Aspiration Devices

4.4.3.2.1.Market size and forecast

4.4.3.3.Snares

4.4.3.3.1.Market size and forecast

4.5.Embolic protection devices

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market size and forecast, by type

4.5.3.1.Distal filter devices

4.5.3.1.1.Market size and forecast

4.5.3.2.Balloon Occlusion Devices

4.5.3.2.1.Market size and forecast

4.6.Accessory devices

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast
4.6.3.Market size and forecast, by type

4.6.3.1.Microcatheters

4.6.3.1.1.Market size and forecast

4.6.3.2.Microguidewires

4.6.3.2.1.Market size and forecast

CHAPTER 5:NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY

5.1.Overview

5.1.1.Market size and forecast

5.2.Aneurysm

5.2.1.Market size and forecast

5.3.Arteriovenous malformation

5.3.1.Market size and forecast

5.4.Ischemic stroke

5.4.1.Market size and forecast

5.5.Stenosis

5.5.1.Market size and forecast

5.6.Others

5.6.1.Market size and forecast

CHAPTER 6:COMPANY PROFILES

6.1.B. BRAUN MELSUNGEN AG

6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance

6.2.INTEGER HOLDINGS CORPORATION

6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments

6.3.JOHNSON & JOHNSON (CERENOVUS)

6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.3.5.Business performance
6.3.6.Key strategic moves and developments

6.4.MEDTRONIC PLC.

6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance
6.4.6.Key strategic moves and developments

6.5.MERIT MEDICAL SYSTEMS, INC.

6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product portfolio
6.5.5.Business performance

6.6.MICROPORT SCIENTIFIC CORPORATION

6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.6.5.Business performance

6.7.PENUMBRA, INC.

6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance

6.8.SAES GETTERS S.P.A. (MEMRY CORPORATION)

6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Business performance

6.9.STRYKER CORPORATION

6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.9.6.Key strategic moves and developments

6.10.TERUMO CORPORATION (MICROVENTION, INC.)

6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.10.5.Business performance
6.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.HYPERTENSION AND DIABETES IN U.S.
TABLE 02.U.S. NEUROVASCULAR DEVICES MARKET, BY PRODUCT, 2019-2027 ($MILLION)
TABLE 03.EMBOLIZATION DEVICES, BY TYPE 2019–2027($MILLION)
TABLE 04.EMBOLIC COIL MARKET, BY TYPE 2019–2027($MILLION)
TABLE 05.U.S. REVASCULARIZATION DEVICES MARKET, BY TYPE 2019–2027($MILLION)
TABLE 06.U.S THROMBECTOMY DEVICES MARKET, BY TYPE 2019–2027($MILLION)
TABLE 07.U.S. EMBOLIC PROTECTION DEVICES MARKET, BY TYPE 2019–2027($MILLION)
TABLE 08.U.S ACCESSORY DEVICES MARKET, BY TYPE 2019–2027($MILLION)
TABLE 09.NEUROVASCULAR DEVICES MARKET, BY DISEASE PATHOLOGY, 2019–2027 ($MILLION)
TABLE 10.B. BRAUN: COMPANY SNAPSHOT
TABLE 11.B. BRAUN: OPERATING SEGMENTS
TABLE 12.B. BRAUN: PRODUCT PORTFOLIO
TABLE 13.INTEGER: COMPANY SNAPSHOT
TABLE 14.INTEGER: OPERATING SEGMENTS
TABLE 15.INTEGER: PRODUCT PORTFOLIO
TABLE 16.J&J: COMPANY SNAPSHOT
TABLE 17.J&J: OPERATING SEGMENTS
TABLE 18.J&J: PRODUCT PORTFOLIO
TABLE 19.MEDTRONIC: COMPANY SNAPSHOT
TABLE 20.MEDTRONIC: OPERATING SEGMENTS
TABLE 21.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 22.MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
TABLE 23.MERIT MEDICAL SYSTEMS: OERATING SEGMENT
TABLE 24.MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
TABLE 25.MICROPORT: COMPANY SNAPSHOT
TABLE 26.MICROPORT: OPERATING SEGMENTS
TABLE 27.MICROPORT: PRODUCT PORTFOLIO
TABLE 28.PENUMBRA: COMPANY SNAPSHOT
TABLE 29.PENUMBRA: OPERATING SEGMENTS
TABLE 30.PENUMBRA: PRODUCT PORTFOLIO
TABLE 31.SAES GETTERS: COMPANY SNAPSHOT
TABLE 32.SAES GETTERS: OERATING SEGMENT
TABLE 33.SAES GETTERS: PRODUCT PORTFOLIO
TABLE 34.STRYKER: COMPANY SNAPSHOT
TABLE 35.STRYKER: OPERATING SEGMENTS
TABLE 36.STRYKER: PRODUCT PORTFOLIO
TABLE 37.TERUMO: COMPANY SNAPSHOT
TABLE 38.TERUMO: OERATING SEGMENT
TABLE 39.TERUMO: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.U.S. NEUROVASCULAR DEVICES MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES (2018–2020)
FIGURE 03.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2018–2020)
FIGURE 04.DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05.TOP INVESTMENT POCKETS
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIER
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.MODERATE INTENSITY OF RIVALRYS
FIGURE 10.LOW THREAT OF NEW ENTRANTS
FIGURE 11.CRUDE STROKE PREVALENCE (%), 2012–2030
FIGURE 12.GERIATRIC POPULATION (MILLIONS), U.S.
FIGURE 13.IMPACT ANALYSES: U.S. NEUROVASCULAR DEVICES MARKET
FIGURE 14.U.S. EMBOLIZATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 15.CLIPPINGS MARKET, 2019–2027 ($MILLION)
FIGURE 16.BARE DETATCHABLE COIL MARKET, 2019–2027 ($MILLION)
FIGURE 17.COATED DETATCHABLE MARKET, 2019–2027 ($MILLION)
FIGURE 18.COIL ASSIST STENTS MARKET, 2019–2027 ($MILLION)
FIGURE 19.COIL ASSIST BALLOON MARKET, 2019–2027 ($MILLION)
FIGURE 20.U.S REVASCULARIZATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 21.CAROTID ARTERY STENT MARKET, 2019–2027 ($MILLION)
FIGURE 22.FLOW DIVERSION STENT MARKET, 2019–2027 ($MILLION)
FIGURE 23.U.S. THROMBECTOMY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 24.CLOT RETRIEVAL DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 25.SUCTION AND ASPIRATION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 26.SNARES MARKET, 2019–2027 ($MILLION)
FIGURE 27.U.S. EMBOLIC PROTECTION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 28.DISTAL FILTER DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 29.BALLOON OCCLUSION DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 30.U.S. ACCESSORY DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 31.MICROCATHETERS DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 32.MICROGUIDEWIRES DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 33.U.S. ANEURYSM MARKET, 2019–2027 ($MILLION)
FIGURE 34.U.S. ARTERIOVENOUS MALFORMATION MARKET, 2019–2027 ($MILLION)
FIGURE 35.U.S. ISCHEMIC STROKE MARKET, 2019–2027 ($MILLION)
FIGURE 36.U.S. STENOSIS MARKET, 2019–2027 ($MILLION)
FIGURE 37.U.S. OTHERS MARKET, 2019–2027 ($MILLION)
FIGURE 38.B.BRAUN: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.B.BRAUN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 40.B.BRAUN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 41.INTEGER: NET SALES, 2017–2019 ($MILLION)
FIGURE 42.INTEGER: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 43.INTEGER: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 44.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 45.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 46.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 47.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 48.MEDTRONIC REVENUE SHARE, BY SEGMENTS, 2019 (%)
FIGURE 49.MEDTRONIC PLC: REVENUE SHARE, BY REGIONS, 2019 (%)
FIGURE 50.MERIT MEDICAL SYSTEMS: NET SALES, 2017–2019 ($MILLION)
FIGURE 51.MERIT MEDICAL SYSTEMS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 52.MERIT MEDICAL SYSTEMS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 53.MICROPORT: NET SALES, 2017–2019 ($MILLION)
FIGURE 54.MICROPORT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 55.MICROPORT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 56.PENUMBRA: NET SALES, 2017–2019 ($MILLION)
FIGURE 57.PENUMBRA: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 58.PENUMBRA: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 59.SAES GETTERS: NET SALES, 2017–2019 ($MILLION)
FIGURE 60.SAES GETTERS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 61.STRYKER: NET SALES, 2017–2019 ($MILLION)
FIGURE 62.STRYKER: REVENUE SHARE, BY SEGMENT, 2019(%)
FIGURE 63.STRYKER: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 64.TERUMO: NET SALES, 2017–2019 ($MILLION)
FIGURE 65.TERUMO: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 66.TERUMO: REVENUE SHARE, BY REGION, 2019 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[アメリカの神経血管装置市場2020年-2027年:製品別(塞栓装置、血行再建装置、血栓摘出装置、塞栓保護装置、付属装置)、疾患別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆